Open in interactive viewer → charts, metric popovers & call review

Rocket Lab: Record Everything, Except the Share Price

Revenue up 73%, backlog up 52%, Neutron priced at $70M — and the stock still sits 58% below its May high. The gap is the story.
RKLB · Earnings Call · 2026-11-09

Rocket Lab: Record Everything, Except the Share Price

There is a version of this quarter that reads like a clean beat-and-raise: Rocket Lab posted $267.8 million of revenue, its sixth straight record quarter, up 73% year-over-year and above the top of guidance. Backlog leapt to $3.57 billion from $2.4 billion sequentially, across 117 launches and more than 55 spacecraft. Gross margin at 33.6% on a GAAP basis also beat the guide. Peter Beck opened the call with the flourish you'd expect:

“Revenue came in at $268 million, 73% higher than the same quarter last year and $34 million, more than Q2. That's the sixth time in a row for record revenue quarters.” — Peter Beck, Chief Executive Officer · 2026-11-09

And yet the equity is down roughly 24.8% over the last 90 trading days and about 58% from its $150.23 close on 2026-05-27. That is the tension this report sits inside. The business has never been healthier on an operating basis; the multiple has never been less forgiving. At a price-to-revenue multiple of roughly 79x, the market is no longer paying for narrative alone. It wants Neutron flying.

Pricing power is the genuinely new thing

Buried in the backlog headline is the most material strategic shift of the quarter: Rocket Lab is not just selling launches, it is discovering it can ration them. Eight Neutron missions were signed in Q3 at a base price of roughly $70 million each — a step up from the $50–55 million tenor management had used for years. In the August call, Adam Spice framed it as aspiration: “We brought Neutron to market with a $50 million to $55 million ASP with a commitment really not to do any significant discounting for early launches.” — Adam Spice, Chief Financial Officer · 2026-08-10 Three months later that aspiration is a transacted price, and the company is deliberately leaving demand on the table.

We could have actually booked more launches in Q3 for Neutron than we did, but we actually chose to go for higher ASP and lower volumes... I think our bias is we think prices are going to continue to go up. So why sell out all the capacity now at these prices even.

Adam Spice, Chief Financial Officer · 2026-11-09

That is a launch market so tight that the seller can refuse revenue. It shows up in the launch capacity narrative throughout the transcript — first 16 Neutrons booked, next slots in the 2030s — and in the smaller vehicle too, where Spice now expects demand for launch across Electron and HASTE to drive price increases rather than discounting. The company also disclosed a $150 million Office of Strategic Capital loan at SOFR plus 100 basis points, non-dilutive money that underscores how central launch capacity has become to policy.

The Neutron date nobody will give

The offset: Neutron's first flight has slipped again, to 2027, after voids were found in the propellant tank's forward dome. This is not new information — it was pre-announced in October — but the call crystallized how much credibility management is now spending on dates. Beck flatly refused to commit:

“We haven't provided guidance on that just yet because we need to get through the Stage 1 tank. And I think if I provide a date, clearly, I've been wrong... I just don't want to be continually wrong.” — Peter Beck, Chief Executive Officer · 2026-11-09

The reflexive read is that this is a fresh stumble. The prior-call record says otherwise: the cadence has been a moving target for at least a year. In May, Beck was already guarded — “I don't think we have enough visibility to narrow it down to a couple of weeks and a quarter at this point in time.” — Peter Beck, CEO · 2026-05-08 — and the sequence of pushes (late 2025, then early 2026, then Q4 2026, now 2027) is exactly why the stock has de-rated even as revenue compounds. The Neutron launch timeline is the single largest source of variance in the equity, and management has now effectively stopped guiding on it, substituting weekly tank-build updates for a date.

What is different this time is the parallel work. Because the tank was the bottleneck, the team used the delay to push engine acceptance testing and composite production, so the convergence to Flight 2, 3 and 5 should be faster than a simple linear slip. Beck reiterated the 1-3-5 ramp but conceded pressure to accelerate is "overwhelming." Whether that is real or rhetorical is what the next two quarters will adjudicate.

The optionality nobody is paying for yet

Two forward themes deserve more attention than the tape is giving them. First, data center interest in orbit keeps recurring — it has been the company's top keyword in each of the last two quarters — and Beck remains usefully skeptical: “For me, it's economics. There's a number of kind of key things that have to happen for those economics to close and those key things are extremely difficult.” — Peter Beck, Chief Executive Officer · 2026-11-09 Rocket Lab's angle is the picks-and-shovels silicon cell and power solution, not the data centers themselves.

Second, the Iridium acquisition is now fully financed: roughly $2.4 billion of gross ATM proceeds lifted the balance sheet to about $4.7 billion of cash, restricted cash and marketable securities, letting the company terminate its $3.6 billion bridge. That cash pile is the reason effective net cash reaching roughly $4.6 billion. Once closed, Iridium brings recurring, cash-generative services revenue and, eventually, its own Neutron launch demand. It is the piece that turns this from a launch story into an end-to-end space infrastructure story.

The bear case writes itself: free cash flow remains deeply negative, R&D is still climbing, and every quarter of Neutron slippage extends the burn. The fundamentals confirm the shape — free cash flow of roughly -$130 million in the latest reported quarter — and the company guided Q4 free cash flow to stay elevated. But the Space Systems engine is now the majority of revenue and growing fast, softening the launch lumpiness that used to define the model.

The verdict

This is a company whose operating reality and market perception have decoupled. Record revenue, record backlog, a $70 million transacted Neutron price and a freshly fortified balance sheet sit against a 58% drawdown and a launch vehicle that keeps missing its date. The pricing-power discovery is the genuine new signal — a real, company-unique shift that turns the scarcity of launch into margin — but it only matters if Neutron flies. Until then, the market is doing the discounting, and Rocket Lab is left selling the future one tank update at a time.